In February 2019, the French immuno-oncology diagnostics company HalioDx opened its first laboratory in North America. The five-year-old company, a Qiagen spin-off, selected Richmond, VA, as the location of the lab, in part, because the state’s capital city is only a two-hour drive from the FDA’s headquarters in Maryland.
{iframe}https://www.lifescienceleader.com/doc/life-sciences-industry-on-uptick-in-virginia-0001{/iframe}